Dr. Inderbir S. Gill

Dr. Inderbir S. Gill chairs the Catherine and Joseph Aresty Department of Urology and directs the USC Institute of Urology at Keck Medicine of USC, where his leadership aligns kidney, prostate, and bladder specialists with medical oncologists, radiologists, pathologists, genetic counselors, anesthesiologists, pelvic-floor therapists, nutritionists, and bilingual nurse navigators. A dawn conference reviews contrast-enhanced CT, multiparametric MRI, tumor genomic panels, and patient-reported outcomes before the first clinic opens, finalizing operative timing, systemic-therapy sequencing, nephron-sparing pathways, continence coaching, and psychosocial support in one decisive session. Coordinators then compress imaging, tele-visits, and insurance authorizations into a single call, sparing families repeat treks across Los Angeles. A secure portal posts procedure dates, lab trends, wound-care videos, and direct-message links so questions receive answers within hours, converting uncertainty into a detailed, compassionate roadmap. By the end of the first visit, patients understand that every recommendation stems from collective expertise focused on their exact diagnosis.

 

Dr. Gill’s translational program examines hypoxia-inducible signaling, immune microenvironment dynamics, and circulating tumor DNA as drivers of renal-cell-carcinoma invasion and prostate-cancer recurrence. His flagship ARIEL study overlays intraoperative augmented-reality imaging onto robotic consoles during zero-ischemia partial nephrectomy, embedding serial ctDNA tracking, radiomic mapping, and spatial-transcriptomic analysis that reveal occult margins and clonal escape weeks before radiographic change. Parallel organoid and porcine models test radio-frequency and high-intensity-focused-ultrasound prototypes, with single-cell RNA readouts guiding engineering refinements. Tissue, plasma, and imaging data flow into the USC Precision Urology Biobank, linking genomic, epigenomic, and metabolomic profiles to long-term outcomes and powering real-time dashboards surgeons consult during counseling. Participants therefore access therapies synchronized to their tumor biology while advancing standards adopted worldwide.

 

Education and outreach move forward together. Dr. Gill mentors residents through a curriculum pairing robotic-simulation labs, biostatistics workshops, quality-of-life methodology, and narrative-medicine forums so technical rigor never eclipses empathy. Quarterly Men’s and Women’s Urologic Health Seminars—streamed in English, Spanish, and Mandarin—address genetic testing, sexual-function preservation, ostomy care, financial navigation, and caregiver resilience, reaching community clinics from East LA to rural Imperial Valley. Partnerships with county health agencies stage bilingual prostate- and kidney-cancer screening fairs in churches, swap meets, and union halls, narrowing disparities where late-stage presentation persists. Policy advocacy within national societies secures coverage for tumor-agnostic sequencing and tele-urology second opinions, proving that discovery, education, and equity can progress in concert. Families see a leader who innovates, teaches, and listens with equal dedication.